{"doi":"10.5009/gnl.2014.8.4.408","title":"Treatment Outcome for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma according to<i>Helicobacter pylori</i>Infection Status: A Single-Center Experience","abstract":null,"journal":"Gut and Liver","year":2014,"id":656071,"datarank":0.5101796072493234,"base_score":3.4011973816621555,"endowment":3.4011973816621555,"self_citation_contribution":0.5101796072493234,"citation_network_contribution":0.0,"self_endowment_contribution":0.5101796072493234,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":29,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1712589,"name":"Gwang Ha Kim","orcid":null,"position":1,"is_corresponding":false},{"id":1587136,"name":"Seong Oh Park","orcid":null,"position":2,"is_corresponding":false},{"id":1712591,"name":"Kwang Jae Lee","orcid":null,"position":3,"is_corresponding":false},{"id":1712593,"name":"Jung Youn Moon","orcid":null,"position":4,"is_corresponding":false},{"id":1712594,"name":"Hye Kyung Jeon","orcid":null,"position":5,"is_corresponding":false},{"id":1712595,"name":"Dong Hoon Baek","orcid":null,"position":6,"is_corresponding":false},{"id":1712596,"name":"Bong Eun Lee","orcid":null,"position":7,"is_corresponding":false},{"id":1712598,"name":"Geun Am Song","orcid":null,"position":8,"is_corresponding":false},{"id":1712587,"name":"Kwang Duck Ryu","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Treatment Outcome for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma according to<i>Helicobacter pylori</i>Infection Status: A Single-Center Experience","abstract":"BACKGROUND/AIMS: Helicobacter pylori eradication therapy has been used as a first-line treatment for H. pylori-positive gastric mucosa-associated lymphoid tissue (MALT) lymphoma. However, the management strategy for H. pylori-negative MALT lymphoma remains controversial. Therefore, the aim of this study was to examine the success rate of each treatment option for H. pylori-positive and H. pylori-negative gastric MALT lymphomas. METHODS: In total, 57 patients with gastric MALT lymphoma diagnosed between December 2000 and June 2012 were enrolled in the study. The treatment responses were compared between H. pylori-positive and H. pylori-negative gastric MALT lymphomas. RESULTS: Of the 57 patients, 43 (75%) had H. pylori infection. Forty-eight patients received H. pylori eradication as a first-line treatment, and complete remission was achieved in 31 of the 39 patients (80%) with H. pylori-positive MALT lymphoma and in five (56%) of the nine patients with H. pylori-negative MALT lymphoma; no significant difference was observed between the groups (p=0.135). The other treatment modalities, including radiation therapy, chemotherapy, and surgery, were effective irrespective of H. pylori infection status, with no significant difference in the treatment response between H. pylori-positive and H. pylori-negative MALT lymphomas. CONCLUSIONS: H. pylori eradication therapy may be considered as a first-line treatment regardless of H. pylori infection status.","is_dataset_classified":null,"base_score":3.4011973816621555,"endowment":3.4011973816621555,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"25071906","pmcid":"PMC4113048","openalex_id":"https://openalex.org/W1999823808","authors":[],"funders":[],"total_grants":0,"fwci":1.403,"citation_percentile":0.79308595,"influential_citations":0,"citation_trend":[{"year":2014,"count":1},{"year":2015,"count":1},{"year":2016,"count":4},{"year":2017,"count":1},{"year":2019,"count":4},{"year":2020,"count":2},{"year":2021,"count":1},{"year":2022,"count":4},{"year":2023,"count":3},{"year":2024,"count":3},{"year":2025,"count":3},{"year":2026,"count":2}],"oa_status":"gold","license":"cc-by-nc","oa_locations":[{"url":"https://doi.org/10.5009/gnl.2014.8.4.408","host_type":"journal"},{"url":"https://doi.org/10.5009/gnl.2014.8.4.408","host_type":"publisher"},{"url":"http://pdf.medrang.co.kr/ekjg/ekjg008-04-12.pdf","host_type":"publisher"},{"url":"https://pubmed.ncbi.nlm.nih.gov/25071906","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4113048","host_type":"repository"},{"url":"https://doaj.org/article/0322735a7e82465fb651a609cfbc1477","host_type":"repository"},{"url":"https://europepmc.org/articles/PMC4113048","host_type":"Europe_PMC"},{"url":"https://europepmc.org/articles/PMC4113048?pdf=render","host_type":"Europe_PMC"}],"fields_of_study":["Lymphoma Diagnosis and Treatment","Lymphadenopathy Diagnosis and Analysis","Helicobacter pylori-related gastroenterology studies"],"mesh_terms":["Adult","Aged","Antineoplastic Agents","Female","Gastric Mucosa","Gastroscopy","Humans","Male","Middle Aged","Retrospective Studies","Stomach Neoplasms","Helicobacter pylori","Helicobacter Infections","Treatment Outcome","Lymphoma, B-Cell, Marginal Zone"],"keywords":["Helicobacter pylori","Medicine","MALT lymphoma","Gastroenterology","Internal medicine","Mucosa-associated lymphoid tissue","Lymphoma","Gastric lymphoma","Gastric mucosa","Lymphatic system","Single Center","Stomach","Immunology","B-cell","Radiotherapy","eradication","Marginal Zone"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-11T19:45:53.538813Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}